The stock of Illumina Inc (ILMN) has seen a -2.80% decrease in the past week, with a 15.41% gain in the past month, and a 29.88% flourish in the past quarter. The volatility ratio for the week is 3.42%, and the volatility levels for the past 30 days are at 3.26% for ILMN. The simple moving average for the last 20 days is 2.48% for ILMN’s stock, with a simple moving average of -14.34% for the last 200 days.
Is It Worth Investing in Illumina Inc (NASDAQ: ILMN) Right Now?
The 36-month beta value for ILMN is at 1.37. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 5 rating it as “overweight,” 10 as “hold,” and 0 as “sell.”
The public float for ILMN is 153.72M, and currently, shorts hold a 4.10% of that float. The average trading volume for ILMN on July 09, 2025 was 2.24M shares.
ILMN) stock’s latest price update
Illumina Inc (NASDAQ: ILMN)’s stock price has dropped by -3.90% in relation to previous closing price of $99.27. Nevertheless, the company has seen a loss of -2.80% in its stock price over the last five trading days. zacks.com reported 2025-06-26 that ILMN jumps 2.9% after striking a $350M deal to acquire SomaLogic and boost its fast-growing multiomics strategy.
Analysts’ Opinion of ILMN
Many brokerage firms have already submitted their reports for ILMN stocks, with Citigroup repeating the rating for ILMN by listing it as a “Neutral.” The predicted price for ILMN in the upcoming period, according to Citigroup is $90 based on the research report published on March 04, 2025 of the current year 2025.
HSBC Securities, on the other hand, stated in their research note that they expect to see ILMN reach a price target of $100. The rating they have provided for ILMN stocks is “Hold” according to the report published on February 28th, 2025.
Barclays gave a rating of “Underweight” to ILMN, setting the target price at $100 in the report published on February 10th of the current year.
ILMN Trading at 11.60% from the 50-Day Moving Average
After a stumble in the market that brought ILMN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.10% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ILMN starting from Dhingra Ankur, who purchase 6,100 shares at the price of $81.21 back on May 12 ’25. After this action, Dhingra Ankur now owns 24,906 shares of Illumina Inc, valued at $495,381 using the latest closing price.
Thaysen Jacob, the Chief Executive Officer of Illumina Inc, purchase 6,500 shares at $80.88 during a trade that took place back on May 12 ’25, which means that Thaysen Jacob is holding 77,540 shares at $525,732 based on the most recent closing price.
Stock Fundamentals for ILMN
Current profitability levels for the company are sitting at:
- 0.36 for the present operating margin
- 0.66 for the gross margin
The net margin for Illumina Inc stands at -0.22. The total capital return value is set at 0.33. Equity return is now at value -23.82, with -11.90 for asset returns.
Based on Illumina Inc (ILMN), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at 0.38. The debt to equity ratio resting at 1.1. The interest coverage ratio of the stock is 14.75.
Currently, EBITDA for the company is -725.0 million with net debt to EBITDA at -3.21. When we switch over and look at the enterprise to sales, we see a ratio of 3.85. The receivables turnover for the company is 6.2for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.86.
Conclusion
In conclusion, Illumina Inc (ILMN) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
